Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women

Completed · Phase 1 · Has a placebo group

Conditions studied: Breast Cancer, Endometrial Cancer

In brief

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of genistein may be effective in preventing breast or endometrial cancer. PURPOSE: This randomized phase I trial is studying the effectiveness of genistein in preventing breast or endometrial cancer in healthy postmenopausal women.

Key facts

Study ID

NCT00099008

Run by

UNC Lineberger Comprehensive Cancer Center

People needed

30

Starts

2004-03-01

Expected to finish

2006-07-01

Last updated by the study team

2013-05-21

Who can join

Age: 45 and older, up to 70. Sex: female. Healthy volunteers: accepted.

Where it is running

• Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill — Chapel Hill, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.